Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Friday rejected AstraZeneca‘s legal challenge to Medicare’s new power … Read more

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

Federal judge tosses lobbying group’s lawsuit challenging Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical … Read more

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Sen. Bernie Sanders, left, appears at a news conference with Sen. Ed Markey on issuing subpoenas for pharmaceutical company CEOs to testify regarding drug prices, in the Capitol, Jan. 25, 2024. Bill Clark | Cq-roll Call, Inc. | Getty Images Senators will question the CEOs of … Read more

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

Fourth-quarter earnings are shaping up to be the best of 2023, but there’s a catch

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., February 1, 2024.  Brendan McDermid | Reuters Here’s how big of a surprise corporate profits have been this earnings season: the fourth-quarter is now shaping up to be the … Read more

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth.  Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by … Read more

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

Healthy Returns: J&J, Merck and Bristol Myers Squibb are in the hot seat

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika Kim Constantino, and I cover the biotech and pharmaceutical industry for CNBC.com.  Three names in the industry – Johnson & Johnson, Merck and … Read more

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Johnson & Johnson (NYSE: JNJ) to the podium.  NYSE Big pharmaceutical companies such as Bristol Myers Squibb, Merck and Johnson & Johnson face a looming threat that will put tens of billions of dollars in sales at risk between now … Read more

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE US Senator Bernie Sanders, Independent of Vermont, speaks during a rally by the People’s Action, protesting pharmaceutical companies’ lobbying against allowing Medicare to negotiate lower prescription drug prices, outside Pharmaceutical Research and Manufacturers of America (PhRMA) headquarters in Washington, DC, September 21, 2021. Saul Loeb | … Read more

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

4 stock ideas I brought back from the JPMorgan Healthcare Conference and everything else I learned about the industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Health care may be a real challenger to tech this year, a business that can actually grow faster than most of tech and has the possibility of a comeback from the Covid straitjacket that so many of these companies got caught up in. The pandemic obscured … Read more

Biden administration’s Medicare drug price negotiations will face major tests in 2024

Biden administration’s Medicare drug price negotiations will face major tests in 2024

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare … Read more

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces  billion deal

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The New York Stock Exchange welcomes Bristol Myers Squibb on Nov. 20th, 2020. NYSE Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock popped more than 47% on the news … Read more

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition

Bristol Myers Squibb results top estimates as new drugs post strong sales growth 

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition.  Bristol Myers, one of the world’s largest pharmaceutical companies, raked in … Read more

Drugmakers opt in to Medicare drug price negotiations – here’s what happens next

Drugmakers opt in to Medicare drug price negotiations – here’s what happens next

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, … Read more

Federal judge declines to block Medicare price negotiations

Federal judge declines to block Medicare price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday declined to block the Biden administration from implementing Medicare drug price negotiations, upholding for now … Read more

AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations

AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images AstraZeneca and Boehringer Ingelheim on Wednesday told CNBC they will agree to participate in the first round of … Read more

Judge withdraws from Medicare drug price case after stock ownership is revealed

Judge withdraws from Medicare drug price case after stock ownership is revealed

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Ohio Governor Mike DeWine, right, shakes hands with Judge Thomas Rose of the U.S. District Court Southern District of Ohio after taking his oath of office, Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge on Friday withdrew from a case … Read more

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

Medicare wants to cut the price on an Eli Lilly drug. What is means for LLY shares

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply … Read more

Medicare drug price negotiations may have a muted impact on drugmakers in the near term

Medicare drug price negotiations may have a muted impact on drugmakers in the near term

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those … Read more

Here are the three most used drugs on the Medicare price negotiation list

Here are the three most used drugs on the Medicare price negotiation list

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Bottles of the drug Jardiance, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters Two blood thinners and a diabetes medication are the most widely used among a list of ten drugs … Read more

Biden administration unveils first 10 drugs subject to Medicare price negotiations

Biden administration unveils first 10 drugs subject to Medicare price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.  President … Read more

These 10 medications are likely targets for Medicare price negotiations this fall

These 10 medications are likely targets for Medicare price negotiations this fall

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in … Read more

Johnson & Johnson is suing the Biden administration over Medicare drug price negotiations

Johnson & Johnson is suing the Biden administration over Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pavlo Gončar | LightRocket | Getty Images Johnson & Johnson sued the Biden administration on Tuesday over new Medicare powers to lower drug prices, becoming the third drug company to challenge the law’s controversial inflation-reduction provision. The lawsuit, filed in federal district court in New Jersey, … Read more

Medicare will allow drug companies to publicly discuss drug price negotiations

Medicare will allow drug companies to publicly discuss drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Hundreds of 1199SEIU health workers staged a rally and sit-in to block 3rd Avenue, where some were arrested. They were protesting health care cuts in Gov. Kathy Hochuls’ Medicare budget. Lev Radin | Lightrocket | Getty Images Medicare said Friday it will allow drug companies to … Read more

A pharmaceutical trade group is suing the Biden administration over Medicare drug price negotiations

A pharmaceutical trade group is suing the Biden administration over Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Traders work at the New York Stock Exchange during morning trading on April 10, 2023 in New York. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued The Biden administration is over New Medicare mandates reduce … Read more

Drugmakers want Supreme Court to block Medicare drug price negotiations

Drugmakers want Supreme Court to block Medicare drug price negotiations

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Pharmaceutical CEOs testify before the Senate Finance Committee on “Drug Prices in America: A Prescription for Change, Part II” on February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, Chairman and CEO of AbbVie Inc; Pascal Soriot, CEO and Managing Director … Read more

The GOP bill slashed Big Pharma’s tax rates by 40%, a Senate report says

The GOP bill slashed Big Pharma’s tax rates by 40%, a Senate report says

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE (L-R) Richard A. Gonzalez, Chairman and CEO of AbbVie Inc., Pascal Soriot, CEO and CEO of AstraZeneca, Giovanni Caforio, Chairman and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO … Read more

The Biden administration will select the top 10 drugs for Medicare price negotiations by September

The Biden administration will select the top 10 drugs for Medicare price negotiations by September

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE The Department of Health and Human Services plans to release a list of 10 Medicare-covered drugs for price negotiations in September, the first stage in a long-awaited push to lower costs for the elderly. Speaking to reporters Wednesday, HHS officials outlined the federal government’s plan to … Read more

Here’s what to watch out for as J&J prepares to split into two separate companies next year

Here’s what to watch out for as J&J prepares to split into two separate companies next year

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Johnson & Johnson ( JNJ ) is preparing to spin off its consumer health unit into a public company next year that will be separate from its pharmaceutical and medical technology businesses. Ahead of the split, Morgan Stanley issued a research note highlighting some of the … Read more

Passage of the Inflation Reduction Act gives Medicare historic new powers over drug prices

Passage of the Inflation Reduction Act gives Medicare historic new powers over drug prices

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE A pharmacist collects drugs for prescriptions at the pharmacy. Simon Dawson | Bloomberg | Getty Images Medicare is poised to renegotiate the prices of some of its most expensive drugs in a historic expansion of its power that could cut costs for many seniors as well … Read more

The study finds that having a woman in the boardroom or leadership leads to even greater diversity

The study finds that having a woman in the boardroom or leadership leads to even greater diversity

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE shironosov | Getty Images If you want to make a good guess about a company’s gender diversity, you might want to first look at who its CEO or board chairman is, according to the findings of a new study. Having a female CEO head a company … Read more

Senate confirms Biden FDA chooses Califa, despite objections to links to drug industry

Senate confirms Biden FDA chooses Califa, despite objections to links to drug industry

MY NUMBER 1 RECOMMENDATION TO LOSE WEIGHT: CLICK HERE Robert Califf testified during a hearing of the Senate Committee on Health, Education, Labor and Pensions on his nomination for Commissioner of the Food and Drug Administration on Tuesday, December 14, 2021. Bill Clark | CQ-Roll Call, Inc. | Getty Images On Tuesday, the Senate confirmed … Read more

;
error: Content is protected !!